Drug Shortage Report for APO-BECLOMETHASONE NASAL SPRAY
| Report ID | 102543 |
| Drug Identification Number | 02238796 |
| Brand name | APO-BECLOMETHASONE NASAL SPRAY |
| Common or Proper name | BECLOMETHASONE |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BECLOMETHASONE DIPROPIONATE |
| Strength(s) | 50MCG |
| Dosage form(s) | SUSPENSION |
| Route of administration | NASAL |
| Packaging size | 200 doses |
| ATC code | R01AD |
| ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-01-06 |
| Estimated end date | 2020-03-06 |
| Actual end date | 2020-03-06 |
| Shortage status | Resolved |
| Updated date | 2020-03-09 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2020-03-09 | French | Compare |
| v6 | 2020-03-09 | English | Compare |
| v5 | 2020-02-28 | French | Compare |
| v4 | 2020-02-28 | English | Compare |
| v3 | 2020-02-28 | English | Compare |
| v2 | 2020-01-08 | French | Compare |
| v1 | 2020-01-08 | English | Compare |
Showing 1 to 7 of 7